Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
P3 Health Partners Inc. | Director | Class A Common Stock | 860K | $1.21M | $1.41 | Oct 23, 2023 | G&K Investment Holdings LLC |
OptimizeRx Corp | Director | Common Stock | 47.3K | $506K | $10.70 | Jun 7, 2024 | Direct |
P3 Health Partners Inc. | Director | Class A Common Stock | 217K | $305K | $1.41 | Oct 23, 2023 | Direct |
OptimizeRx Corp | Director | Restricted Stock Units | 0 | $0 | $10.70 | Jun 5, 2024 | Direct |
P3 Health Partners Inc. | Director | Stock Option (Right to Buy) | 483K | Jun 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PIII | P3 Health Partners Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
OPRX | OptimizeRx Corp | Jun 5, 2024 | 3 | $0 | 4 | Jun 11, 2024 | Director |
PIII | P3 Health Partners Inc. | Oct 23, 2023 | 1 | $0 | 4 | Jan 25, 2024 | Director |
OPRX | OptimizeRx Corp | Jun 7, 2023 | 3 | $0 | 4 | Aug 18, 2023 | Director |
OPRX | OptimizeRx Corp | Mar 31, 2023 | 2 | $0 | 4 | Apr 3, 2023 | Director |
OPRX | OptimizeRx Corp | Dec 30, 2022 | 2 | $0 | 4 | Jan 4, 2023 | Director |
OPRX | OptimizeRx Corp | Sep 29, 2022 | 2 | $0 | 4 | Sep 30, 2022 | Director |
OPRX | OptimizeRx Corp | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
OPRX | OptimizeRx Corp | Mar 30, 2022 | 1 | $0 | 4 | Apr 1, 2022 | Director |
PIII | P3 Health Partners Inc. | Mar 24, 2022 | 1 | $0 | 4 | Mar 28, 2022 | Director |
OPRX | OptimizeRx Corp | Dec 30, 2021 | 1 | $0 | 4 | Jan 3, 2022 | Director |
PIII | Foresight Acquisition Corp. | Oct 4, 2021 | 2 | $0 | 4 | Oct 6, 2021 | Director, 10%+ Owner |
OPRX | OptimizeRx Corp | Sep 29, 2021 | 1 | $0 | 4 | Oct 1, 2021 | Director |
OPRX | OptimizeRx Corp | Jun 30, 2021 | 1 | $0 | 4 | Jun 30, 2021 | Director |